Acadia Healthcare Company, Inc. $ACHC Stock Holdings Cut by Wellington Management Group LLP

Key Points

• Wellington Management Group LLP reduced its stake in Acadia Healthcare by 7.3%, selling 862,015 shares, and now holds 10,872,728 shares or approximately 11.80% of the company.
• Acadia Healthcare reported earnings of $0.83 per share in the last quarter, exceeding analyst expectations, with a revenue increase of 9.2% year-over-year.
• Research firms have varied ratings on Acadia Healthcare, with Barclays lowering its target price from $28.00 to $20.00 while other analysts maintain a consensus rating of "Moderate Buy" with a target price of $40.77.

Wellington Management Group LLP reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,872,728 shares of the company's stock after selling 862,015 shares during the quarter. Wellington Management Group LLP owned approximately 11.80% of Acadia Healthcare worth $329,661,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its position in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after acquiring an additional 1,234 shares in the last quarter. UMB Bank n.a. lifted its stake in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. State of Wyoming acquired a new position in Acadia Healthcare in the fourth quarter worth $56,000. Covestor Ltd boosted its holdings in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the period. Finally, Aquatic Capital Management LLC bought a new stake in Acadia Healthcare during the fourth quarter valued at $97,000.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Barclays decreased their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. UBS Group decreased their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Guggenheim dropped their price target on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Mizuho cut their price target on Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a report on Wednesday, August 13th. Finally, Stephens upgraded Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Nine investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $40.77.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded up $1.02 during mid-day trading on Friday, hitting $22.44. 1,602,123 shares of the company's stock traded hands, compared to its average volume of 2,578,314. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $82.40. The firm has a 50 day moving average price of $21.92 and a 200 day moving average price of $26.12. The company has a market cap of $2.07 billion, a PE ratio of 14.86, a price-to-earnings-growth ratio of 4.42 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.